ONGOING TRIAL: A PHASE I/II STUDY OF TAFASITAMAB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED CENTRAL NERVOUS SYSTEM LYMPHOMA.

M. Randall, J. Wilmoth, S. Zilberman, J. Roselli, A. Rauschecker, L. Chen, M. Lu, H. Geng, A. Afshar, H. Abdulhaq, J. L. Rubenstein. ONGOING TRIAL: A PHASE I/II STUDY OF TAFASITAMAB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED CENTRAL NERVOUS SYSTEM LYMPHOMA. Hematological Oncology. 2025 Jun 15; 43(S3).

2025
https://researcherprofiles.org/profile/628480926

M. Randall, J. Wilmoth, S. Zilberman, J. Roselli, A. Rauschecker, L. Chen, M. Lu, H. Geng, A. Afshar, H. Abdulhaq, J. L. Rubenstein